Clinical trial delays often originate in early site selection decisions, where misalignment between protocol demands and site capabilities undermines startup, enrollment, and data quality despite later efforts to correct course.
Chris Matheus
Advertisement
Chris Matheus is a Partner at Global Life Sciences Alliance (GLSA) and brings over 30 years of experience in the life sciences and clinical research industry. He has worked extensively across research sites, CROs, and industry stakeholders, with a focus on strengthening collaboration, improving feasibility alignment, and supporting more effective trial execution. His work centers on connecting people, processes, and practical strategies to help clinical research programs operate more efficiently.
Articles by Chris Matheus
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Data Harmonization Imperative: How AI Is Solving Clinical Research's Biggest Bottleneck
2
Patient Engagement Strategies in Anti-Obesity Medication Clinical Trials: Addressing Drop Out Rate and Improving Retention
3
SCOPE X: How AI Could Reshape the Sponsor-Site Relationship Over the Next Several Years
4
SCOPE X: What Real-Time Patient Data Is Doing to ClinOps Efficiency
5